These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 32426300)

  • 1. Neurotransmitter Testing of the Urine: A Comprehensive Analysis [Expression of Concern].
    Res Rep Urol; 2020; 12():147. PubMed ID: 32426300
    [No Abstract]   [Full Text] [Related]  

  • 2. Power of Orbitrap-based LC-high resolution-MS/MS for comprehensive drug testing in urine with or without conjugate cleavage or using dried urine spots after on-spot cleavage in comparison to established LC-MS
    Michely JA; Meyer MR; Maurer HH
    Drug Test Anal; 2018 Jan; 10(1):158-163. PubMed ID: 28755512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary Neurotransmitter Testing: Considerations of Spot Baseline Norepinephrine and Epinephrine [Expression of Concern].
    Res Rep Urol; 2020; 12():145. PubMed ID: 32426299
    [No Abstract]   [Full Text] [Related]  

  • 4. Validity of Urinary Monoamine Assay Sales Under the "Spot Baseline Urinary Neurotransmitter Testing Marketing Model" [Expression of Concern].
    Int J Nephrol Renovasc Dis; 2020; 13():73. PubMed ID: 32425578
    [No Abstract]   [Full Text] [Related]  

  • 5. Definitive urine drug testing in office-based opioid treatment: a literature review.
    Barthwell AG; Allgaier J; Egli K
    Crit Rev Toxicol; 2018 Nov; 48(10):829-852. PubMed ID: 30794024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated urine arsenic: un-speciated results lead to unnecessary concern and further evaluations.
    Kales SN; Huyck KL; Goldman RH
    J Anal Toxicol; 2006 Mar; 30(2):80-5. PubMed ID: 16620536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testing urine samples with rK39 strip as the simplest non-invasive field diagnosis for visceral leishmaniasis: an early report from eastern India.
    Goswami RP; Goswami RP; Das S; Ray Y; Rahman M
    J Postgrad Med; 2012; 58(3):180-4. PubMed ID: 23023349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adulteration of urine drug testing--an exaggerated cause of concern].
    Beck O; Bohlin M; Bragd F; Bragd J; Greitz O
    Lakartidningen; 2000 Feb; 97(7):703-6. PubMed ID: 10740378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urine-based HPV testing as a method to screen for cervical cancer.
    Fontenot HB
    Nurs Womens Health; 2015; 19(1):59-65. PubMed ID: 25690816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paper Spray Ionization Coupled to High Resolution Tandem Mass Spectrometry for Comprehensive Urine Drug Testing in Comparison to Liquid Chromatography-Coupled Techniques after Urine Precipitation or Dried Urine Spot Workup.
    Michely JA; Meyer MR; Maurer HH
    Anal Chem; 2017 Nov; 89(21):11779-11786. PubMed ID: 29022692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotransmitters excreted in the urine as biomarkers of nervous system activity: validity and clinical applicability.
    Marc DT; Ailts JW; Campeau DC; Bull MJ; Olson KL
    Neurosci Biobehav Rev; 2011 Jan; 35(3):635-44. PubMed ID: 20696183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple metal exposures and their correlation with monoamine neurotransmitter metabolism in Chinese electroplating workers.
    Wu LL; Gong W; Shen SP; Wang ZH; Yao JX; Wang J; Yu J; Gao R; Wu G
    Chemosphere; 2017 Sep; 182():745-752. PubMed ID: 28535482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability studies of amphetamine and ephedrine derivatives in urine.
    Jiménez C; de la Torre R; Ventura M; Segura J; Ventura R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Oct; 843(1):84-93. PubMed ID: 16798115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and clinical evaluation of a dried urine spot method for detection of morphine among opioid users.
    Jain R; Quraishi R; Verma A; Ambekar A
    Indian J Pharmacol; 2019; 51(1):40-44. PubMed ID: 31031466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demystifying analytical approaches for urine drug testing to evaluate medication adherence in chronic pain management.
    McMillin GA; Slawson MH; Marin SJ; Johnson-Davis KL
    J Pain Palliat Care Pharmacother; 2013 Dec; 27(4):322-39. PubMed ID: 24147959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent substance intake among patients admitted to acute psychiatric wards: physician's assessment and on-site urine testing compared with comprehensive laboratory analyses.
    Mordal J; Holm B; Mørland J; Bramness JG
    J Clin Psychopharmacol; 2010 Aug; 30(4):455-9. PubMed ID: 20631563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating Novel Markers for Specimen Validity Testing.
    Kyle PB; Kaur J
    Arch Pathol Lab Med; 2020 Feb; 144(2):168-171. PubMed ID: 31755779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost and Efficacy Assessment of an Alternative Medication Compliance Urine Drug Testing Strategy.
    Doyle K; Strathmann FG
    Pain Med; 2017 Feb; 18(2):307-315. PubMed ID: 28204701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing the Incidence of Substance Use Disorders in Anesthesiology Residents: 13 Years of Comprehensive Urine Drug Screening.
    Fitzsimons MG; Baker K; Malhotra R; Gottlieb A; Lowenstein E; Zapol WM
    Anesthesiology; 2018 Oct; 129(4):821-828. PubMed ID: 30020101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dried urine spots - A novel sampling technique for comprehensive LC-MS
    Michely JA; Meyer MR; Maurer HH
    Anal Chim Acta; 2017 Aug; 982():112-121. PubMed ID: 28734350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.